Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen

Pomila Singh, Marco Velasco, Randall Given, Andrea Varro, Timothy C. Wang

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Background and Aims: Processing intermediates of preprogastrin (gly- gastrin and progastrin), termed nonamidated gastrins, are mitogenic for several cell types including colonic epithelial cells. However, presently it is not known if nonamidated gastrins play a role in colon carcinogenesis and if the effects are similar to those of amidated gastrins. Methods: Colon carcinogenesis in response to azoxymethane (AOM) was examined in transgenic mice overexpressing either progastrin (hGAS) or amidated gastrin (INS-GAS), compared with that in wild-type (WT) mice. Results: In AOM-treated groups, the total number of tumors per colon was significantly higher in hGAS (4.8 ± 0.34) than INS-GAS (3.0 ± 0.16) and WT (2.7 ± 0.35) mice. Total numbers of adenocarcinomas and adenomas per animal colon were also significantly higher in hGAS than INS-GAS and WT mice. The size of the tumors was greater in hGAS mice, resulting in a significantly higher tumor burden per mouse in the hGAS mice than INS-GAS and WT mice. Although >90% of the tumors were located in the distal half of the colon in INS-GAS and WT mice, a significant number (42%) were present at the proximal end the colon in hGAS mice. Conclusions: The results suggest that the risk for developing colon carcinomas and adenomas in response to AOM is significantly increased in mice expressing high levels of progastrin, but not amidated gastrins.

Original languageEnglish (US)
Pages (from-to)162-171
Number of pages10
JournalGastroenterology
Volume119
Issue number1
StatePublished - Jul 2000

Fingerprint

Carcinogens
Adenoma
Colon
Carcinoma
Gastrins
Azoxymethane
Carcinogenesis
big gastrin
Neoplasms
Tumor Burden
Transgenic Mice
Adenocarcinoma
Epithelial Cells

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. / Singh, Pomila; Velasco, Marco; Given, Randall; Varro, Andrea; Wang, Timothy C.

In: Gastroenterology, Vol. 119, No. 1, 07.2000, p. 162-171.

Research output: Contribution to journalArticle

Singh, Pomila ; Velasco, Marco ; Given, Randall ; Varro, Andrea ; Wang, Timothy C. / Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. In: Gastroenterology. 2000 ; Vol. 119, No. 1. pp. 162-171.
@article{cd408cb03b7e459e8bc8b619d47551fc,
title = "Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen",
abstract = "Background and Aims: Processing intermediates of preprogastrin (gly- gastrin and progastrin), termed nonamidated gastrins, are mitogenic for several cell types including colonic epithelial cells. However, presently it is not known if nonamidated gastrins play a role in colon carcinogenesis and if the effects are similar to those of amidated gastrins. Methods: Colon carcinogenesis in response to azoxymethane (AOM) was examined in transgenic mice overexpressing either progastrin (hGAS) or amidated gastrin (INS-GAS), compared with that in wild-type (WT) mice. Results: In AOM-treated groups, the total number of tumors per colon was significantly higher in hGAS (4.8 ± 0.34) than INS-GAS (3.0 ± 0.16) and WT (2.7 ± 0.35) mice. Total numbers of adenocarcinomas and adenomas per animal colon were also significantly higher in hGAS than INS-GAS and WT mice. The size of the tumors was greater in hGAS mice, resulting in a significantly higher tumor burden per mouse in the hGAS mice than INS-GAS and WT mice. Although >90{\%} of the tumors were located in the distal half of the colon in INS-GAS and WT mice, a significant number (42{\%}) were present at the proximal end the colon in hGAS mice. Conclusions: The results suggest that the risk for developing colon carcinomas and adenomas in response to AOM is significantly increased in mice expressing high levels of progastrin, but not amidated gastrins.",
author = "Pomila Singh and Marco Velasco and Randall Given and Andrea Varro and Wang, {Timothy C.}",
year = "2000",
month = "7",
language = "English (US)",
volume = "119",
pages = "162--171",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen

AU - Singh, Pomila

AU - Velasco, Marco

AU - Given, Randall

AU - Varro, Andrea

AU - Wang, Timothy C.

PY - 2000/7

Y1 - 2000/7

N2 - Background and Aims: Processing intermediates of preprogastrin (gly- gastrin and progastrin), termed nonamidated gastrins, are mitogenic for several cell types including colonic epithelial cells. However, presently it is not known if nonamidated gastrins play a role in colon carcinogenesis and if the effects are similar to those of amidated gastrins. Methods: Colon carcinogenesis in response to azoxymethane (AOM) was examined in transgenic mice overexpressing either progastrin (hGAS) or amidated gastrin (INS-GAS), compared with that in wild-type (WT) mice. Results: In AOM-treated groups, the total number of tumors per colon was significantly higher in hGAS (4.8 ± 0.34) than INS-GAS (3.0 ± 0.16) and WT (2.7 ± 0.35) mice. Total numbers of adenocarcinomas and adenomas per animal colon were also significantly higher in hGAS than INS-GAS and WT mice. The size of the tumors was greater in hGAS mice, resulting in a significantly higher tumor burden per mouse in the hGAS mice than INS-GAS and WT mice. Although >90% of the tumors were located in the distal half of the colon in INS-GAS and WT mice, a significant number (42%) were present at the proximal end the colon in hGAS mice. Conclusions: The results suggest that the risk for developing colon carcinomas and adenomas in response to AOM is significantly increased in mice expressing high levels of progastrin, but not amidated gastrins.

AB - Background and Aims: Processing intermediates of preprogastrin (gly- gastrin and progastrin), termed nonamidated gastrins, are mitogenic for several cell types including colonic epithelial cells. However, presently it is not known if nonamidated gastrins play a role in colon carcinogenesis and if the effects are similar to those of amidated gastrins. Methods: Colon carcinogenesis in response to azoxymethane (AOM) was examined in transgenic mice overexpressing either progastrin (hGAS) or amidated gastrin (INS-GAS), compared with that in wild-type (WT) mice. Results: In AOM-treated groups, the total number of tumors per colon was significantly higher in hGAS (4.8 ± 0.34) than INS-GAS (3.0 ± 0.16) and WT (2.7 ± 0.35) mice. Total numbers of adenocarcinomas and adenomas per animal colon were also significantly higher in hGAS than INS-GAS and WT mice. The size of the tumors was greater in hGAS mice, resulting in a significantly higher tumor burden per mouse in the hGAS mice than INS-GAS and WT mice. Although >90% of the tumors were located in the distal half of the colon in INS-GAS and WT mice, a significant number (42%) were present at the proximal end the colon in hGAS mice. Conclusions: The results suggest that the risk for developing colon carcinomas and adenomas in response to AOM is significantly increased in mice expressing high levels of progastrin, but not amidated gastrins.

UR - http://www.scopus.com/inward/record.url?scp=0034235903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034235903&partnerID=8YFLogxK

M3 - Article

VL - 119

SP - 162

EP - 171

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 1

ER -